Finally, the high expression of CSF2 in breast cancer is associated with more CC chemokine ligand 18 (CCL18)+ macrophage infiltration, epithelial-mesenchymal transition (EMT), enhanced metastasis, and reduced patient survival (18). The gene discussed is CSF2; the disease is breast cancer.